Drug Approved for Heart Failure in Black Patients
A drug aimed at treating heart failure specifically in black patients has proved so effective that the clinical trial in which it was being tested has been halted early, the company sponsoring the...
View ArticleIdeas & Trends; Race-Based Medicine Continued...
Many people, including some African-Americans, have long been uneasy with the concept of race-based medicine, in part from fear that it may legitimize less benign ideas about race.
View ArticleU.S. to Review Drug Intended For One Race
A drug marketed to African-Americans has engendered controversy as scientists say that race is too ill-defined a category to be relevant in determining a drug's approval.
View ArticleF.D.A. Approves a Heart Drug for African-Americans
The Food and Drug Administration took a controversial step toward a new frontier of personalized medicine.
View Article2 Officials Quit Amid Slow Sales of Heart Drug for Blacks
A new drug hailed last year as a breakthrough for black heart patients has not lived up to expectations for NitroMed.
View ArticleClik here to view.
From Bang to Whimper: A Heart Drug’s Story
American medicine managed to take a small step forward and a giant step backward at precisely the same time with BiDil, a drug designed to treat heart failure in blacks.
View ArticleRace and Medicine (2 Letters)
Letters to the editor about the heart drug BiDil, independence for the elderly and recovery after trauma.
View Article